Loading...
Loading...
Loading...
Loading...

Citations for Anti CDR2 pAb (ATL-HPA023870 w/enhanced validation)

Eichler, Tilo W; Totland, Cecilie; Haugen, Mette; Qvale, Tor H; Mazengia, Kibret; Storstein, Anette; Haukanes, Bjørn I; Vedeler, Christian A. CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration. Plos One. 8(6):e66002. PubMed

Schubert, Manja; Panja, Debabrata; Haugen, Mette; Bramham, Clive R; Vedeler, Christian A. Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis. Acta Neuropathologica. 2014;128(6):835-52. PubMed

Panja, D; Vedeler, C A; Schubert, M. Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity. Neuropathology And Applied Neurobiology. 2019;45(2):141-156. PubMed

Herdlevær, Ida; Haugen, Mette; Mazengia, Kibret; Totland, Cecilie; Vedeler, Christian. Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic Marker. Neurology(R) Neuroimmunology & Neuroinflammation. 2021;8(2) PubMed

Anti CDR2 pAb [Catalog No.: ATL-HPA023870] - cosmobiousa